Priority Date: 18.05.12 (US 201261649220P)

METABOLITES OF (1R-TRANS)-N-[[2-(2,3-DIHYDRO-4-BENZOFURANYL)CYCLOPROPYL]METHYL]PROPANAMIDE

  • Application ID: EP13724708
  • Status: EXAMINATION IN PROGRESS

Attorney

Employment test 51 - 200 employees
Company dna appleyard lees ltd
operating since 1852
Headquarter in Halifax and 15 offices
active in Legal Services, IP Consulting, Matchmaking and Trading, and IP-related Communication Service

Specialization

This patent has the IPC combination A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) and C07 (ORGANIC CHEMISTRY) is specialized in the combination A61 and C07. We found, that TransMIT GmbH, Kailuweit & Uhlemann, Lederer Keller Patentanwälte Partnerschaft mbB, Vossius & Partner Patentanwälte Rechtsanwälte mbB, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB and 186 others are specialized in all of these IPC classes. For a similar patent, they might be a good choice.

Timeline

  • 18.05.2012 - Priority Date (US 201261649220P)
  • 21.11.2013 - Publication A1 (WO2013173707)
  • 08.04.2015 - Publication A1 (EP2855424)